Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres (Q44794986)
scientific article published in April 2004
Language:
(P31) (Q13442814)
(P50) (Q89006575)
(Q89655459)
(Q94703174)
(P304) 99-110
(P433) 1
(P478) 44
(P577) Thursday, April 1, 2004
(P921) (Q42824440)
(Q181600)
(Q61643320)
(Q412616)
(Q412415)
(P1433) (Q641464)
(P1476) "Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpres" (language: en)
(P2093) Ralph G Zinner
Bonnie S Glisson
Katherine M W Pisters
Merril S Kies
Pamela M Lee
Bradley Sabloff
Herbert A Fritsche
Jae Y Ro
Nelson G Ordonez
Hai T Tran
Ying Yang
Terry L Smith
Robert D Mass
other details
description scientific article published in April 2004

External Links